Gender features of comorbidity in patients with coronary artery disease

A N Sumin1, E V Korok1, A V Shcheglova1

  • 1Research Institute for Complex Issues of Cardiovascular Disease, Kemerovo, Russia.

Terapevticheskii Arkhiv
|February 1, 2019
PubMed

Insights

High comorbidity in coronary artery disease (CAD) patients is linked to diabetes, lung disease, and atherosclerosis in both sexes. Gender-specific factors also influence comorbidity levels, necessitating tailored clinical approaches.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Public Health

Background:

  • Coronary artery disease (CAD) frequently presents with multiple comorbidities, impacting patient outcomes.
  • Understanding gender-specific factors associated with comorbidity is crucial for effective CAD management.

Purpose of the Study:

  • To identify and analyze factors contributing to high comorbidity levels in male and female patients with coronary artery disease (CAD).
  • To explore gender-specific predictors of elevated comorbidity in the CAD population.

Main Methods:

  • Analysis of data from 742 patients (595 men, 147 women) undergoing pre-operative screening for coronary artery bypass grafting.
  • Comparison of comorbidity prevalence and associated factors between male and female patient groups.
  • Statistical analysis to determine independent predictors of high comorbidity levels.

Main Results:

  • Arterial hypertension and atrial fibrillation were more prevalent in women; post-infarction cardiosclerosis (PIC) in men.
  • Men generally presented with lower functional classes of angina and chronic heart failure (CHF) stage I, while women showed higher classes and stage III CHF.
  • Diabetes mellitus, thyroid disease, varicose veins, and bronchial asthma (BA) were more common in women; chronic hepatitis and urolithiasis in men. Common predictors for high comorbidity included diabetes, chronic lung disease, PIC, and atherosclerotic lesions of the arteries of the lower extremities (ALE).

Conclusions:

  • A significant proportion of CAD patients exhibit high comorbidity (13.6% women, 11.6% men).
  • Diabetes, chronic lung disease, PIC, and ALE atherosclerosis are common comorbidity predictors in both genders.
  • Gender-specific factors like angina functional class IV, peptic ulcer disease, and BA in women, and 'underground experience' in men, are also associated with high comorbidity, underscoring the need for gender-tailored clinical strategies.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
426
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
368
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
684
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
933